Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Noseda

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|May 1, 1970
Blood flow measurement through single coronary arteries by roentgen densitometry. Right coronary artery flow in conscious manW Rutishauser, G Noseda, W D Bussmann, et al.
Schweizerische Medizinische Wochenschrift|June 29, 1985
[Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]H Schiffl, P Weidmann, C Fragiacomo, et al.
Schweizerische Medizinische Wochenschrift|January 3, 1970
[Hereditary periodic adynamia. Studies on the renin-angiotensin-aldosterone system]G Noseda, F Regli, E Esslen, et al.
Schweizerische Medizinische Wochenschrift|June 19, 1971
[Binding of beta-lipoprotein by an IgA paraprotein: an antigen-antibody reaction?]G Noseda, R Bütler, E Schlumpf, et al.
International Journal of Clinical Pharmacology Research|January 1, 1988
Comparative absorption kinetics of imidazole and salicylic acid in volunteers after administration of ITF 182 tablets and suppositoriesG Noseda, C Fragiacomo, M Peruzzi, et al.
Schweizerische Medizinische Wochenschrift|December 8, 1979
[Treatment of hyperlipidemia type II with soybeans]G Noseda, C Fragiacomo, C Bosia, et al.
Schweizerische Medizinische Wochenschrift|August 18, 1979
[Clofibrate--helpful or harmful?]G Hartmann, H Micheli, R Mordasini, et al.
European Heart Journal|May 16, 2002
Short-term effects of atorvastatin on C-reactive proteinW F Riesen, H Engler, M Risch, et al.
Obesity Research|March 11, 2000
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study GroupS Rössner, L Sjöström, R Noack, et al.
Biochemical Pharmacology|May 8, 1992
The dispositional enantioselectivity of indobufen in manM Strolm Benedetti, E Frigerio, V Tamassia, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|May 1, 1970
Blood flow measurement through single coronary arteries by roentgen densitometry. Right coronary artery flow in conscious manW Rutishauser, G Noseda, W D Bussmann, et al.
Schweizerische Medizinische Wochenschrift|June 29, 1985
[Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]H Schiffl, P Weidmann, C Fragiacomo, et al.
Schweizerische Medizinische Wochenschrift|January 3, 1970
[Hereditary periodic adynamia. Studies on the renin-angiotensin-aldosterone system]G Noseda, F Regli, E Esslen, et al.
Schweizerische Medizinische Wochenschrift|June 19, 1971
[Binding of beta-lipoprotein by an IgA paraprotein: an antigen-antibody reaction?]G Noseda, R Bütler, E Schlumpf, et al.
International Journal of Clinical Pharmacology Research|January 1, 1988
Comparative absorption kinetics of imidazole and salicylic acid in volunteers after administration of ITF 182 tablets and suppositoriesG Noseda, C Fragiacomo, M Peruzzi, et al.
Schweizerische Medizinische Wochenschrift|December 8, 1979
[Treatment of hyperlipidemia type II with soybeans]G Noseda, C Fragiacomo, C Bosia, et al.
Schweizerische Medizinische Wochenschrift|August 18, 1979
[Clofibrate--helpful or harmful?]G Hartmann, H Micheli, R Mordasini, et al.
European Heart Journal|May 16, 2002
Short-term effects of atorvastatin on C-reactive proteinW F Riesen, H Engler, M Risch, et al.
Obesity Research|March 11, 2000
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study GroupS Rössner, L Sjöström, R Noack, et al.
Biochemical Pharmacology|May 8, 1992
The dispositional enantioselectivity of indobufen in manM Strolm Benedetti, E Frigerio, V Tamassia, et al.
Pageof 11